Next Article in Journal

Long-Term Immunogenicity and Safety of a Homologous Third Dose Booster Vaccination with TURKOVAC: Phase 2 Clinical Study Findings with 32-Week Post-Booster Follow-Up

Next Article in Special Issue

New Approaches to the Prevention of Visceral Leishmaniasis: A Review of Recent Patents of Potential Candidates for a Chimeric Protein Vaccine

Previous Article in Journal

Enhanced Downstream Processing for a Cell-Based Avian Influenza (H5N1) Vaccine

Previous Article in Special Issue

Evaluation of a Vaccine Candidate Designed for Broad-Spectrum Protection against Type A Foot-and-Mouth Disease in Asia

You seem to have javascript disabled. Please note that many of the page functionalities won't work as expected without javascript enabled.

Search for Articles:

Title / Keyword

Author / Affiliation / Email

Journal

Article Type

Advanced Search

Section

Special Issue

Volume

Issue

Number

Page

Logical OperatorOperator

Search Text

Search Type

Submit to this Journal Review for this Journal Propose a Special Issue

Article Menu

Share Help Cite Discuss in SciProfiles

Open AccessArticle

Article Versions Notes

Vaccines 2024, 12(2), 139; https://doi.org/10.3390/vaccines12020139

Action	Date	Notes	Link
article xml file uploaded	29 January 2024 10:21 CET	Original file	-
article xml uploaded.	29 January 2024 10:21 CET	Update	https://www.mdpi.com/2076-393X/12/2/139/xml
article pdf uploaded.	29 January 2024 10:21 CET	Version of Record	https://www.mdpi.com/2076-393X/12/2/139/pdf
article supplementary file uploaded.	29 January 2024 10:21 CET	-	https://www.mdpi.com/2076-393X/12/2/139#supplementary
article html file updated	29 January 2024 10:23 CET	Original file	-
article html file updated	24 June 2025 10:18 CEST	Update	https://www.mdpi.com/2076-393X/12/2/139/html

Back to TopTop